Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Uribe

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Molecular Pharmaceutics|October 26, 2024
Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled [Pro<sup>14</sup>]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing CancerLei Wang, Hsiou-Ting Kuo, Devon E Chapple, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 TherapyJulia Brosch-Lenz, Astrid Delker, Friederike Völter, et al.
EJNMMI Physics|January 15, 2022
Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesionsRoberto Fedrigo, Dan J Kadrmas, Patricia E Edem, et al.
Journal of the Neurological Sciences|December 17, 2015
Diagnostic yield of the palmomental reflex in patients with suspected frontal lesionLady D Ladino, Sandra Isaza, Jorge Delgado, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After InjectionSurekha Yadav, Fei Jiang, Sara Kurkowska, et al.
Neuroendocrinology|June 12, 2026
Comparison of [111In]octreotide scintigraphy and [68Ga]DOTATOC PET in GEP-NETs: concordance of Krenning scores and implications for PRRT treatment eligibilityRoberto Fedrigo, Sara Harsini, Luke Murtha, et al.
The Journal of Urology|January 10, 2004
Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: initial clinical useDavid I Lee, Carlos Uribe, Louis Eichel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate CancerIvica J Bratanovic, Chengcheng Zhang, Zhengxing Zhang, et al.
PET Clinics|November 21, 2025
Artificial Intelligence for Simplified Patient-centered Dosimetry in Radiopharmaceutical TherapiesAlejandro Lopez Montes, Fereshteh Yousefirizi, Yizhou Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
First-in-Human Evaluation of [<sup>68</sup>Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate CancerGuillaume Chaussé, Xinchi Hou, Carlos Uribe, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Molecular Pharmaceutics|October 26, 2024
Synthesis and Evaluation of <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled [Pro<sup>14</sup>]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing CancerLei Wang, Hsiou-Ting Kuo, Devon E Chapple, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 19, 2023
Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 TherapyJulia Brosch-Lenz, Astrid Delker, Friederike Völter, et al.
EJNMMI Physics|January 15, 2022
Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesionsRoberto Fedrigo, Dan J Kadrmas, Patricia E Edem, et al.
Journal of the Neurological Sciences|December 17, 2015
Diagnostic yield of the palmomental reflex in patients with suspected frontal lesionLady D Ladino, Sandra Isaza, Jorge Delgado, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 9, 2024
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After InjectionSurekha Yadav, Fei Jiang, Sara Kurkowska, et al.
Neuroendocrinology|June 12, 2026
Comparison of [111In]octreotide scintigraphy and [68Ga]DOTATOC PET in GEP-NETs: concordance of Krenning scores and implications for PRRT treatment eligibilityRoberto Fedrigo, Sara Harsini, Luke Murtha, et al.
The Journal of Urology|January 10, 2004
Sealing percutaneous nephrolithotomy tracts with gelatin matrix hemostatic sealant: initial clinical useDavid I Lee, Carlos Uribe, Louis Eichel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate CancerIvica J Bratanovic, Chengcheng Zhang, Zhengxing Zhang, et al.
PET Clinics|November 21, 2025
Artificial Intelligence for Simplified Patient-centered Dosimetry in Radiopharmaceutical TherapiesAlejandro Lopez Montes, Fereshteh Yousefirizi, Yizhou Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
First-in-Human Evaluation of [<sup>68</sup>Ga]Ga-HTK03149, a PSMA-Targeted Tracer for PET Imaging in Prostate CancerGuillaume Chaussé, Xinchi Hou, Carlos Uribe, et al.
Pageof 9